Show simple item record

dc.contributor.authorKisely, Stephen
dc.contributor.authorCampbell, Leslie Anne
dc.date.accessioned2017-05-03T14:18:19Z
dc.date.available2017-05-03T14:18:19Z
dc.date.issued2008
dc.date.modified2010-11-04T07:05:55Z
dc.identifier.issn1172-7047
dc.identifier.urihttp://hdl.handle.net/10072/22423
dc.description.abstractAbstract: Individuals with mental illness are particularly disadvantaged by their use of tobacco, spending as much as 40% of their income on cigarettes. They also have increased mortality from cardiovascular and respiratory disorders. The most effective interventions to help psychiatric patients stop smoking are similar to those that are effective in the general population. These include psychological treatments, nicotine replacement therapy (NRT), bupropion and nortriptyline, at least in the short term. Most studies agree that these gains can be achieved in the absence of significant adverse effects in terms of psychological morbidity. Effects diminish over time, but these findings also apply to the general population. The best long-term results have come from extended prescription and psychological interventions, and apply equally to patients with and without a history of psychiatric disorder, such as major depression. In spite of this, clinicians are not fully exploiting opportunities to help psychiatric patients stop smoking. It is not possible to plan a programme to help individuals stop smoking in mental health settings unless factors such as demographics, diagnosis and concurrent medication are taken into account. Copyright 2008 Adis Data Information BV
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherAdis International
dc.publisher.placeNew Zealand
dc.publisher.urihttps://link.springer.com/article/10.2165/00023210-200822040-00001
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom263
dc.relation.ispartofpageto273
dc.relation.ispartofissue4
dc.relation.ispartofjournalCNS Drugs
dc.relation.ispartofvolume22
dc.rights.retentionY
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchNeurosciences
dc.subject.fieldofresearchPharmacology and pharmaceutical sciences
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode3209
dc.subject.fieldofresearchcode3214
dc.titleUse of Smoking Cessation Therapies in Individuals with Psychiatric Illness: an update for prescribers
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.rights.copyright© 2008 Adis Data Information BV. Self-archiving of the author-manuscript version is not yet supported by this publisher. Please refer to the journal link for access to the definitive, published version or contact the authors for more information.
gro.date.issued2008
gro.hasfulltextNo Full Text
gro.griffith.authorKisely, Steve R.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record